【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Schizophrenia Therapeutics Market in the US
06.3.1 Market Size and Forecast
06.4 Five Forces Analysis
07.Pipeline Snapshot
08.Rate of Incidence and Prevalence
08.1.1 US
09.Types of Schizophrenia
10.Phases of Schizophrenia
11.Market Segmentation by Drug Class
12.Geographical Segmentation
12.1 Schizophrenia Therapeutics Market in Americas
12.1.1 Market Size and Forecast
12.2 Schizophrenia Therapeutics Market in the APAC Region
12.2.1 Market Size and Forecast
12.3 Schizophrenia Therapeutics Market in the EMEA Region
12.3.1 Market Size and Forecast
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2013
20.3 Other Prominent Vendors
21.Key Vendor Analysis
21.1 AstraZeneca
21.1.1 Key Facts
21.1.2 Business Description
21.1.3 Business Segmentation
21.1.4 Business Strategy
21.1.5 Revenue by Business Segmentation
21.1.6 Revenue Comparison 2011-2013
21.1.7 Sales Revenue by Geographical Segmentation
21.1.8 Key Developments
21.1.9 SWOT Analysis
21.2 Bristol-Myers Squibb Co.
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Product Segmentation
21.2.4 Sales by Geography
21.2.5 Business Strategy
21.2.6 Key Information
21.2.7 SWOT Analysis
21.3 Eli Lilly and Co.
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2013
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Sales by Geography
21.3.6 Business Strategy
21.3.7 Key Developments
21.3.8 SWOT Analysis
21.4 F. Hoffmann-La Roche
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation
21.4.4 Business Segmentation by Revenue 2012 and 2013
21.4.5 Geographical Segmentation by Revenue
21.4.6 Business Strategy
21.4.7 Key Information
21.4.8 SWOT Analysis
21.5 H. Lundbeck
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Product Segmentation by Revenue 2013
21.5.4 Product Segmentation by Revenue 2012 and 2013
21.5.5 Geographical Segmentation by Revenue 2013
21.5.6 Business Strategy
21.5.7 Recent Developments
21.5.8 SWOT Analysis
21.6 Johnson & Johnson
21.6.1 Key Facts
21.6.2 Business Overview
21.6.3 Business Segmentation by Revenue 2013
21.6.4 Business Segmentation by Revenue 2012 and 2013
21.6.5 Geographical Segmentation by Revenue 2013
21.6.6 Business Strategy
21.6.7 Recent Developments
21.6.8 SWOT Analysis
21.7 Otsuka Pharmaceuticals
21.7.1 Key Facts
21.7.2 Business Overview
21.7.3 Business Segmentation by Revenue 2014
21.7.4 Business Segmentation by Revenue 2013 and 2014
21.7.5 Geographical Segmentation by Revenue 2014
21.7.6 Business Strategy
21.7.7 Recent Developments
21.7.8 SWOT Analysis
21.8 Pfizer Inc.
21.8.1 Key Facts
21.8.2 Business Description
21.8.3 Business Segmentation
21.8.4 Revenue by Business Segmentation
21.8.5 Revenue Comparison 2012 and 2013
21.8.6 Sales by Geography
21.8.7 Business Strategy
21.8.8 Key Developments
21.8.9 SWOT Analysis
21.9 Sumitomo Dainippon Pharma
21.9.1 Key Facts
21.9.2 Business Overview
21.9.3 Product Segmentation
21.9.4 Products Segmentation by Revenue 2013 and 2014
21.9.5 Business Strategy
21.9.6 Recent Developments
21.9.7 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Schizophrenia Therapeutics Market 2013-2018 (US$ billion)
Exhibit 3: Schizophrenia Therapeutics Market in the US
Exhibit 4: Types of Schizophrenia
Exhibit 5: Phases of Schizophrenia
Exhibit 6: Global Schizophrenia Therapeutics Market Segmentation by Drug Class
Exhibit 7: Global Schizophrenia Therapeutics Market by Geographical Segmentation 2013
Exhibit 8: Schizophrenia Therapeutics Market in America 2013-2018 (US$ billion)
Exhibit 9: Schizophrenia Therapeutics Market in the APAC Region 2013-2018 (US$ billion)
Exhibit 10: Schizophrenia Therapeutics Market in the EMEA Region 2013-2018 (US$ billion)
Exhibit 11: Global Schizophrenia Therapeutics Market by Geographical Segmentation 2013-2018 (US$ billion)
Exhibit 12: Global Schizophrenia Therapeutics Market by Geographical Segmentation 2013-2018 (in percent)
Exhibit 13: Johnson & Johnson Sales by Therapeutic Area (Pharmaceuticals) 2013
Exhibit 14: AstraZeneca: Business Segmentation
Exhibit 15: AstraZeneca: Revenue by Business Segmentation 2013
Exhibit 16: AstraZeneca: Revenue by Business Segmentation 2011-2013 (US$ billion)
Exhibit 17: AstraZeneca: Sales Revenue by Geographical Segmentation 2013
Exhibit 18: Bristol-Myers Squibb Co.: Product Segmentation (Based on Therapeutic Areas)
Exhibit 19: Bristol-Myers Squibb Co.: Sales by Geography 2013
Exhibit 20: Eli Lilly and Co.: Business Segmentation by Revenue 2013
Exhibit 21: Eli Lilly and Co.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 22: Eli Lilly and Co.: Sales by Geography 2013
Exhibit 23: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 24: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 25: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
Exhibit 26: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
Exhibit 27: H. Lundbeck: Business Segmentation by Revenue 2013
Exhibit 28: H. Lundbeck: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 29: H. Lundbeck: Geographical Segmentation by Revenue 2013
Exhibit 30: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 31: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 32: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Exhibit 33: Otsuka Pharmaceutical: Business Segmentation by Revenue 2014
Exhibit 34: Otsuka Pharmaceutical: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 35: Otsuka Pharmaceutical: Geographical Segmentation by Revenue 2014
Exhibit 36: Pfizer Inc.: Business Segmentation
Exhibit 37: Pfizer Inc.: Revenue by Business Segmentation 2013
Exhibit 38: Pfizer Inc.: Revenue by Business Segmentation 2012 and 2013
Exhibit 39: Pfizer Inc.: Revenue by Geography 2013
Exhibit 40: Sumitomo Dainippon Pharma: Product Segmentation 2014
Exhibit 41: Sumitomo Dainippon Pharma: Product Segmentation by Revenue 2013 and 2014
【レポート販売概要】
■ タイトル：統合失調症（Schizophrenia）治療薬の世界市場■ 英文：Global Schizophrenia Therapeutics Market 2014-2018
■ 発行日：2014年11月19日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4716
■ 調査対象地域：グローバル
- 農業機械向け融資の世界市場2019-2023About this market Agricultural equipment finance provides quick and easy access to credit unlike traditional financial institutions, which may take more than a day to complete the paperwork for the loan application. Many banks also have policies that encourage them to provide loans to farmers due to government support. In addition, alternative finance caters to such businesses by providing quick a …
- 世界のゼロ・カロリー甘味料市場動向（2014～2018）TechNavio's analysts forecast the Global Zero-calorie Sweetener market to grow at a CAGR of 4.69 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing health-consciousness across the world. The Global Zero-calorie Sweetener market has also been witnessing the rise in consumer income levels in emerging countries. However, the negative criticisms …
- 胃内バルーンの世界市場2015-2019About Intragastric Balloon Obesity is a medical condition associated with the accumulation of excess fat. A person with a body mass index of 30 or more is considered obese. According to the WHO, more than 1.9 billion adults aged 18 years and above were overweight in 2014. Worldwide there are more than 671 million obese people, particularly in countries such as the US, Brazil, Belgium, Mexico, Germ …
- 心血管系超音波検査システムの世界市場予測2021：経胸壁心エコー図、経食道心エコー図、負荷心エコー図The cardiovascular ultrasound system market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, growing at a CAGR of 5.4% during the forecast period. Increasing incidence of cardiovascular diseases, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures is driving the growth of this market. However, insufficient reimburs …
- 世界における交流送電システム向け高電圧スイッチギヤ市場TechNavio’s analysts forecast the Global High Voltage Switchgear for AC Transmission System market to grow at a CAGR of 7.89 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapid global industrialization. The market has also been witnessing an increased steady adoption of innovative high voltage switchgear from conventional high voltage switchgea …
- 世界のリテールバンキングIT市場動向（2012-2016）TechNavio's analysts forecast the Global Retail Banking IT market to grow at a CAGR of 4.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need for customer satisfaction. The Global Retail Banking IT market has also been witnessing increasing need to comply with banking regulatory policies. However, meeting the diverse demands of custo …
- Anything-as-a-Service（XaaS）の世界市場2016-2020About the Anything-as-a-Service (XaaS) Market XaaS is a cloud computing term that delivers a variety of services and applications to users via the Internet. XaaS also known as everything-as-a-service refers to the increasing number of services delivered through cloud over the Internet rather than providing locally or on-premises. The most common service types of XaaS are software-as-a-service (Saa …
- 関節リウマチ（Rheumatoid Arthritis）治療薬の世界市場予測および分析PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) and the prevalence is expected to grow t …
- ハンドバッグの世界市場2019-2023About this market The rapid Internet penetration helps manufacturers offer product information to consumers in a convenient manner, thereby making purchases easy and driving the growth of the global handbag market. Owing to their busy schedules, consumers prefer shopping online. The adoption of digital products such as tablets, smartphones, and laptops have further boosted the online sales of hand …
- 小動物向け画像診断機器（イン・ビトロ）の世界市場予測（～2021年）：光学イメージング、PET、SPECT、CT、MRI、超音波、光音響画像化装置、磁気粒子画像装置The global small animal imaging market is expected to reach a value of USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016-2021. A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researche …
- フレキシブルディスプレイの世界市場2015-2019About Flexible Display Flexible displays are next-generation electronic display screens, which are thin, lightweight, foldable, and bendable. These displays can be rolled up without damaging their display capabilities, i.e., they can be manipulated without breaking. Compared to its counterparts, flexible displays are more durable. They are manufactured using plastic or other flexible substrate mat …
- グローバル空港産業サーベイ（2013-2014）：市場動向、マーケティング戦略Why was the report written? This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global airport industry executives. The report provides data and analysis on global airports industry suppliers’ media spend, marketing and sales strategies, and practices and business planning within the global airports industry. This report includes key topics such as …
- 患者登録ソフトウェアの世界市場予測（～2021）The patient registry software market is segmented on the basis of product type, pricing model, deployment model, type of database, functionality, end user, and region. Based on product type, the patient registry software market is segmented into integrated and standalone software. The standalone software segment is expected to account for the largest market share in 2016. This can be attributed to …
- 中耳炎(Otitis Media)の治療薬パイプライン動向（2015年上半期版）Otitis Media - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Otitis Media - Pipeline Review, H1 2015’, provides an overview of the Otitis Media’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Otitis Media, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), ro …
- 石油精製の世界市場：石油精製能力、投資動向Global Refining Industry Outlook to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries Summary "Global Refining Industry Outlook to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries" is a comprehensive report on global crude oil refining industry. The report provides refinery details such as re …
